INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
HOUSE PTR/Partial saleVerified data

Kevin Hern sold NVO

Self · NOVO NORDISK A S · Novo Nordisk A/S Common Stock

Side
SELL
Value range
$1,001 – $15K
Shares
Not disclosed
Price
—
Executed
Aug 31, 2026
Disclosed
Sep 25, 2026
Disclosure timeline25 days from execution to publication · legal deadline 45 days
Aug 31 executedSep 25, 2026 disclosed

NVO · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
20/ 100 · ROUTINE
Methodology →
  • Transaction type+10 / 20

    Partial sale

  • Relative size+2 / 25

    Disclosed range starting at $1K

  • Filing timing0 / 15

    Disclosed 25 days after execution (STOCK Act deadline: 45)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · NVO

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    16
    Kevin HernRSelf
    NVONOVO NORDISK A S
    Sale
    		SELL$1,001 – $15KSep 10, 2026Sep 25, 2026
    traded Sep 10, 2026
    		+15dHOUSE PTR

    Evidence

    24
    Scott FranklinRSelf
    NVONOVO NORDISK A S
    Purchase
    		BUY$1,001 – $15KAug 26, 2026Sep 17, 2026
    traded Aug 26, 2026
    		+22dHOUSE PTR

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    House Periodic Transaction Report
    Publisher
    Clerk of the U.S. House of Representatives
    Document ID
    20035491

    Timestamps

    Event (reported)
    Aug 31, 2026
    Published
    Sep 25, 2026
    Ingested by INSIDER
    Nov 4, 22:39 UTC
    Last re-read
    Nov 5, 18:11 UTC

    Extracted facts

    Filer
    Kevin Hern
    Role
    Self
    Transaction
    Partial saleAs filed: “S (partial)”
    Asset
    Novo Nordisk A/S Common Stock
    Ticker
    NVO
    Reported value
    $1,001 – $15KAs filed: “$1,001 - $15,000”
    Execution date (reported)
    Aug 31, 2026
    Notification date (reported)
    Sep 15, 2026
    Days from execution to publication
    25

    Calculation

    Midpoint = (low + high) / 2. Used only to rank and sum ranges; the true value can be anywhere in the range.

    • Low: $1,001
    • High: $15,000

    = $8,001

    What this establishes

    Kevin Hern reported a partial sale of Novo Nordisk A/S Common Stock. Members report a value range, not an exact amount, and do not report share counts or prices. Dates are as entered by the filer. A trade report is not evidence of wrongdoing.

    Extraction

    Method
    PDF text extraction
    Confidence
    1.00
    Self
    Kevin Hernbioguide:H001082
    Issuer
    NOVO NORDISK A Scik:0000353278

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.